158 related articles for article (PubMed ID: 18998219)
1. Hormone therapy in relation to survival from large bowel cancer.
Newcomb PA; Chia VM; Hampton JM; Doria-Rose VP; Trentham Dietz A
Cancer Causes Control; 2009 May; 20(4):409-16. PubMed ID: 18998219
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and survival after colorectal cancer diagnosis.
Chan JA; Meyerhardt JA; Chan AT; Giovannucci EL; Colditz GA; Fuchs CS
J Clin Oncol; 2006 Dec; 24(36):5680-6. PubMed ID: 17179103
[TBL] [Abstract][Full Text] [Related]
3. Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study.
Risch HA; Howe GR
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):21-8. PubMed ID: 7894320
[TBL] [Abstract][Full Text] [Related]
4. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
5. The influence of hormone therapies on colon and rectal cancer.
Mørch LS; Lidegaard Ø; Keiding N; Løkkegaard E; Kjær SK
Eur J Epidemiol; 2016 May; 31(5):481-9. PubMed ID: 26758900
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States).
Doria-Rose VP; Newcomb PA; Morimoto LM; Hampton JM; Trentham-Dietz A
Cancer Causes Control; 2006 Feb; 17(1):63-70. PubMed ID: 16411054
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry.
Phipps AI; Robinson JR; Campbell PT; Win AK; Figueiredo JC; Lindor NM; Newcomb PA
Cancer; 2017 May; 123(6):1035-1043. PubMed ID: 27861761
[TBL] [Abstract][Full Text] [Related]
8. Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan.
Kotake K; Honjo S; Sugihara K; Kato T; Kodaira S; Takahashi T; Yasutomi M; Muto T; Koyama Y
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S32-43. PubMed ID: 14530656
[TBL] [Abstract][Full Text] [Related]
9. Interactions of familial and hormonal risk factors for large bowel cancer in women.
Newcomb PA; Taylor JO; Trentham-Dietz A
Int J Epidemiol; 1999 Aug; 28(4):603-8. PubMed ID: 10480684
[TBL] [Abstract][Full Text] [Related]
10. Estrogen replacement therapy and colorectal cancer risk in elderly women.
Paganini-Hill A
Dis Colon Rectum; 1999 Oct; 42(10):1300-5. PubMed ID: 10528768
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.
Hildebrand JS; Jacobs EJ; Campbell PT; McCullough ML; Teras LR; Thun MJ; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2835-41. PubMed ID: 19843681
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic use of hormone therapy and mortality after breast cancer.
Newcomb PA; Egan KM; Trentham-Dietz A; Titus-Ernstoff L; Baron JA; Hampton JM; Stampfer MJ; Willett WC
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):864-71. PubMed ID: 18381475
[TBL] [Abstract][Full Text] [Related]
13. Second primary cancers in subsites of colon and rectum in patients with previous colorectal cancer.
Liu L; Lemmens VE; De Hingh IH; de Vries E; Roukema JA; van Leerdam ME; Coebergh JW; Soerjomataram I
Dis Colon Rectum; 2013 Feb; 56(2):158-68. PubMed ID: 23303143
[TBL] [Abstract][Full Text] [Related]
14. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.
Mulder SA; Kranse R; Damhuis RA; Ouwendijk RJ; Kuipers EJ; van Leerdam ME
Dis Colon Rectum; 2012 May; 55(5):522-31. PubMed ID: 22513430
[TBL] [Abstract][Full Text] [Related]
15. The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years.
Manninen P; Karvonen AL; Huhtala H; Aitola P; Hyöty M; Nieminen I; Hemminki H; Collin P
J Crohns Colitis; 2013 Dec; 7(11):e551-7. PubMed ID: 23619008
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
[TBL] [Abstract][Full Text] [Related]
17. Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study.
Gervaz P; Bucher P; Neyroud-Caspar I; Soravia C; Morel P
Dis Colon Rectum; 2005 Feb; 48(2):227-32. PubMed ID: 15711864
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin.
Nichols HB; Trentham-Dietz A; Hampton JM; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1212-8. PubMed ID: 15894674
[TBL] [Abstract][Full Text] [Related]
19. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project.
Storm HH; Engholm G; Pritzkuleit R; Kejs AM; Katalinic A; Dunst J; Holländer NH
Eur J Cancer; 2015 Jun; 51(9):1188-98. PubMed ID: 25483784
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women.
Kabat GC; Miller AB; Rohan TE
Int J Cancer; 2008 Feb; 122(3):643-6. PubMed ID: 17847020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
